(Q73074996)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Improvement of the systemic prime/oral boost strategy for systemic and local responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Tosca G M Lauterslager

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Wil Stok

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Luuk A T Hilgers

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

number of pages

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

13-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1391-1399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

Vaccination strategies for mucosal immune responses

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Mechanisms of vaccine adjuvanticity at mucosal surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Vaccines and mucosal immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Targeting of drugs and vaccines to the gut.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Mucosal immunity and tolerance: relevance to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Immune responses and side effects of five different oil-based adjuvants in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Evaluation of the efficacy of intraperitoneal immunization in reducing Salmonella typhimurium infection in chickens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Adjuvant properties of stable water-in-oil emulsions: evaluation of the experience with Specol

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

A novel non-mineral oil-based adjuvant. I. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Alkyl-polyacrylate esters are strong mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Alkyl-esters of polyacrylic acid as vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Selection of potent immunological adjuvants for vaccine construction

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Immunological concepts of vaccine adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Influences of microbiota on intestinal immune system development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Oral vaccination with immune stimulating complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

Induction of Oral Tolerance in the Primed Immune System: Influence of Antigen Persistence and Adjuvant Form

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900687-4

7 January 2021

10.1016/S0264-410X(02)00687-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12615435%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference